Reduction in the need of inhaled corticosteroids in children with astmha recieving allergen specific immunotherapy

Rationale One of the described benefits of allergen specific subcutaneous immunotherapy (SCIT) is its potential effect on the reduction of the medication needed for the treatment of allergic diseases.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB153-AB153
Main Authors: Macouzet-Sanchez, Carlos, MD, González-Díaz, Sandra, MD, PhD, FAAAI, Cruz, Alfredo Arias, MD, FAAAAI, Macias-Weinmann, Alejandra, MD, Buenfil-Lopez, Jose Antonio, MD, Partida-Ortega, Alma Belen, MD, Monge-Ortega, Olga Patricia, MD, Ramos-Valencia, Lissette, MD, Ibarra-Chavez, Jesus Arturo, MD
Format: Article
Language:English
Subjects:
Allergy and Immunology
Asthma
Food allergies
Immunotherapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rationale One of the described benefits of allergen specific subcutaneous immunotherapy (SCIT) is its potential effect on the reduction of the medication needed for the treatment of allergic diseases.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.503